☰

Talene A. Yacoubian, Ph.D. - Publications

Affiliations: 
Duke University, Durham, NC 
Tree Info Grants Similar researchers PubMed Report error

34 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Yacoubian TA, Fang YD, Gerstenecker A, Amara A, Stover N, Ruffrage L, Collette C, Kennedy R, Zhang Y, Hong H, Qin H, McConathy J, Benveniste EN, Standaert DG. Brain and Systemic Inflammation in De Novo Parkinson's Disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 36853618 DOI: 10.1002/mds.29363  0.589
2022 Fang YD, McConathy JE, Yacoubian TA, Zhang Y, Kennedy RE, Standaert DG. Image Quantification for TSPO PET with a Novel Image-Derived Input Function Method. Diagnostics (Basel, Switzerland). 12. PMID 35626315 DOI: 10.3390/diagnostics12051161  0.384
2022 Kuo SH, Tasset I, Cheng MM, Diaz A, Pan MK, Lieberman OJ, Hutten SJ, Alcalay RN, Kim S, Ximénez-Embún P, Fan L, Kim D, Ko HS, Yacoubian T, Kanter E, et al. Mutant glucocerebrosidase impairs α-synuclein degradation by blockade of chaperone-mediated autophagy. Science Advances. 8: eabm6393. PMID 35138901 DOI: 10.1126/sciadv.abm6393  0.453
2022 Xu E, Boddu R, Abdelmotilib HA, Sokratian A, Kelly K, Liu Z, Bryant N, Chandra S, Carlisle SM, Lefkowitz EJ, Harms AS, Benveniste EN, Yacoubian TA, Volpicelli-Daley LA, Standaert DG, et al. Pathological α-synuclein recruits LRRK2 expressing pro-inflammatory monocytes to the brain. Molecular Neurodegeneration. 17: 7. PMID 35012605 DOI: 10.1186/s13024-021-00509-5  0.753
2021 Carlisle SM, Qin H, Hendrickson RC, Muwanguzi JE, Lefkowitz EJ, Kennedy RE, Yan Z, Yacoubian TA, Benveniste EN, West AB, Harms AS, Standaert DG. Sex-based differences in the activation of peripheral blood monocytes in early Parkinson disease. Npj Parkinson's Disease. 7: 36. PMID 33850148 DOI: 10.1038/s41531-021-00180-z  0.731
2021 Underwood R, Gannon M, Pathak A, Kapa N, Chandra S, Klop A, Yacoubian TA. 14-3-3 mitigates alpha-synuclein aggregation and toxicity in the in vivo preformed fibril model. Acta Neuropathologica Communications. 9: 13. PMID 33413679 DOI: 10.1186/s40478-020-01110-5  0.422
2020 Underwood R, Wang B, Carico C, Whitaker RH, Placzek WJ, Yacoubian TA. The GTPase Rab27b regulates the release, autophagic clearance, and toxicity of alpha-synuclein. The Journal of Biological Chemistry. PMID 32350025 DOI: 10.1074/Jbc.Ra120.013337  0.514
2018 Wang B, Underwood R, Kamath A, Britain C, McFerrin MB, McLean PJ, Volpicelli-Daley LA, Whitaker RH, Placzek WJ, Becker K, Ma J, Yacoubian TA. 14-3-3 proteins reduce cell-to-cell transfer and propagation of pathogenic alpha-synuclein. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 30093536 DOI: 10.1523/Jneurosci.1134-18.2018  0.49
2017 McFerrin MB, Chi X, Cutter G, Yacoubian TA. Dysregulation of 14-3-3 proteins in neurodegenerative diseases with Lewy body or Alzheimer pathology. Annals of Clinical and Translational Neurology. 4: 466-477. PMID 28695147 DOI: 10.1002/Acn3.421  0.528
2016 Apetauerova D, Scala SA, Hamill RW, Simon DK, Pathak S, Ruthazer R, Standaert DG, Yacoubian TA. CoQ10 in progressive supranuclear palsy: A randomized, placebo-controlled, double-blind trial. Neurology® Neuroimmunology & Neuroinflammation. 3: e266. PMID 27583276 DOI: 10.1212/Nxi.0000000000000266  0.448
2015 Lavalley NJ, Slone SR, Ding H, West AB, Yacoubian TA. 14-3-3 proteins regulate mutant LRRK2 kinase activity and neurite shortening. Human Molecular Genetics. PMID 26546614 DOI: 10.1093/Hmg/Ddv453  0.452
2015 Ding H, Underwood R, Lavalley N, Yacoubian TA. 14-3-3 inhibition promotes dopaminergic neuron loss and 14-3-3θ overexpression promotes recovery in the MPTP mouse model of Parkinson's disease. Neuroscience. 307: 73-82. PMID 26314634 DOI: 10.1016/J.Neuroscience.2015.08.042  0.602
2015 Slone SR, Lavalley N, McFerrin M, Wang B, Yacoubian TA. Increased 14-3-3 phosphorylation observed in Parkinson's disease reduces neuroprotective potential of 14-3-3 proteins. Neurobiology of Disease. 79: 1-13. PMID 25862939 DOI: 10.1016/J.Nbd.2015.02.032  0.599
2015 Ding H, Underwood R, Lavalley N, Yacoubian TA. 14-3-3 inhibition promotes dopaminergic neuron loss and 14-3-3θ overexpression promotes recovery in the MPTP mouse model of Parkinson's disease Neuroscience. 307: 73-82. DOI: 10.1016/j.neuroscience.2015.08.042  0.37
2014 Yacoubian TA, Standaert DG. Reaping what you sow: Cross-seeding between aggregation-prone proteins in neurodegeneration. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 306. PMID 24395732 DOI: 10.1002/Mds.25766  0.484
2013 Yacoubian TA. IPX066: a new intermediate-and extended-release carbidopa-levodopa formulation. Neurodegenerative Disease Management. 3: 123-131. PMID 24501594 DOI: 10.2217/Nmt.13.4  0.534
2013 Ding H, Fineberg NS, Gray M, Yacoubian TA. α-Synuclein overexpression represses 14-3-3θ transcription. Journal of Molecular Neuroscience : Mn. 51: 1000-9. PMID 23912650 DOI: 10.1007/S12031-013-0086-5  0.499
2013 Fraser KB, Moehle MS, Daher JP, Webber PJ, Williams JY, Stewart CA, Yacoubian TA, Cowell RM, Dokland T, Ye T, Chen D, Siegal GP, Galemmo RA, Tsika E, Moore DJ, et al. LRRK2 secretion in exosomes is regulated by 14-3-3. Human Molecular Genetics. 22: 4988-5000. PMID 23886663 DOI: 10.1093/Hmg/Ddt346  0.779
2013 Steidinger TU, Slone SR, Ding H, Standaert DG, Yacoubian TA. Angiogenin in Parkinson disease models: role of Akt phosphorylation and evaluation of AAV-mediated angiogenin expression in MPTP treated mice. Plos One. 8: e56092. PMID 23409128 DOI: 10.1371/Journal.Pone.0056092  0.685
2012 Harrington AJ, Yacoubian TA, Slone SR, Caldwell KA, Caldwell GA. Functional analysis of VPS41-mediated neuroprotection in Caenorhabditis elegans and mammalian models of Parkinson's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 2142-53. PMID 22323726 DOI: 10.1523/Jneurosci.2606-11.2012  0.565
2011 Slone SR, Lesort M, Yacoubian TA. 14-3-3theta protects against neurotoxicity in a cellular Parkinson's disease model through inhibition of the apoptotic factor Bax. Plos One. 6: e21720. PMID 21799745 DOI: 10.1371/Journal.Pone.0021720  0.472
2011 Lee YJ, Wang S, Slone SR, Yacoubian TA, Witt SN. Defects in very long chain fatty acid synthesis enhance alpha-synuclein toxicity in a yeast model of Parkinson's disease. Plos One. 6: e15946. PMID 21264320 DOI: 10.1371/Journal.Pone.0015946  0.358
2011 Steidinger TU, Standaert DG, Yacoubian TA. A neuroprotective role for angiogenin in models of Parkinson's disease. Journal of Neurochemistry. 116: 334-41. PMID 21091473 DOI: 10.1111/J.1471-4159.2010.07112.X  0.69
2010 Yacoubian TA, Slone SR, Harrington AJ, Hamamichi S, Schieltz JM, Caldwell KA, Caldwell GA, Standaert DG. Differential neuroprotective effects of 14-3-3 proteins in models of Parkinson's disease. Cell Death & Disease. 1: e2. PMID 21152247 DOI: 10.1038/Cddis.2009.4  0.744
2010 Standaert DG, Yacoubian TA. Target validation: the Parkinson disease perspective. Disease Models & Mechanisms. 3: 259-62. PMID 20427553 DOI: 10.1242/Dmm.004192  0.525
2009 Yacoubian TA, Howard G, Kissela B, Sands CD, Standaert DG. Racial differences in Parkinson's disease medication use in the reasons for geographic and racial differences in stroke cohort: a cross-sectional study. Neuroepidemiology. 33: 329-34. PMID 19887838 DOI: 10.1159/000254568  0.637
2009 Yacoubian TA, Standaert DG. Targets for neuroprotection in Parkinson's disease. Biochimica Et Biophysica Acta. 1792: 676-87. PMID 18930814 DOI: 10.1016/J.Bbadis.2008.09.009  0.586
2009 Fergenbaum JH, Bruce S, Spence JD, Lou W, Hanley AJG, Greenwood C, Young TK, Béjot Y, Giroud M, Hong C, Darling TN, Lee C, Yacoubian TA, Howard G, Kissela B, et al. Contents Vol. 33, 2009 Neuroepidemiology. 33. DOI: 10.1159/000265101  0.422
2009 Fergenbaum JH, Bruce S, Spence JD, Lou W, Hanley AJG, Greenwood C, Young TK, Béjot Y, Giroud M, Hong C, Darling TN, Lee C, Yacoubian TA, Howard G, Kissela B, et al. Subject Index Vol. 33, 2009 Neuroepidemiology. 33: 362-362. DOI: 10.1159/000265100  0.439
2009 Fergenbaum JH, Bruce S, Spence JD, Lou W, Hanley AJG, Greenwood C, Young TK, Béjot Y, Giroud M, Hong C, Darling TN, Lee C, Yacoubian TA, Howard G, Kissela B, et al. Title Page / Preface Neuroepidemiology. 33: 293-295. DOI: 10.1159/000252941  0.427
2008 Qiao L, Hamamichi S, Caldwell KA, Caldwell GA, Yacoubian TA, Wilson S, Xie ZL, Speake LD, Parks R, Crabtree D, Liang Q, Crimmins S, Schneider L, Uchiyama Y, Iwatsubo T, et al. Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicity. Molecular Brain. 1: 17. PMID 19021916 DOI: 10.1186/1756-6606-1-17  0.606
2008 Yacoubian TA, Cantuti-Castelvetri I, Bouzou B, Asteris G, McLean PJ, Hyman BT, Standaert DG. Transcriptional dysregulation in a transgenic model of Parkinson disease. Neurobiology of Disease. 29: 515-28. PMID 18191405 DOI: 10.1016/J.Nbd.2007.11.008  0.586
2000 Yacoubian TA, Lo DC. Truncated and full-length TrkB receptors regulate distinct modes of dendritic growth. Nature Neuroscience. 3: 342-9. PMID 10725923 DOI: 10.1038/73911  0.524
1999 Kryl D, Yacoubian T, Haapasalo A, Castren E, Lo D, Barker PA. Subcellular localization of full-length and truncated Trk receptor isoforms in polarized neurons and epithelial cells. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 19: 5823-33. PMID 10407023 DOI: 10.1523/Jneurosci.19-14-05823.1999  0.549
Show low-probability matches.